The laboratories of the active pharmaceutical component (API) manufacturer Diva reported consolidated net profit for the June quarter, which had increased by about 27% to ₹ 545 crore a year ago as compared to ₹ 430 crore.
Due to net profit operation, the revenue increased to ₹ 2,410 crore (₹ 2,118 crore) at an increase of about 14%. Serialarily, however, operations both net profit and revenue declined.
The company, which specializes in generic APIs, custom synthesis and neutrasuticals, posted ₹ 2,585 crore for the March quarter and ₹ 2,585 crore from 662 crore net profit and operation. Divi shares on BSE on Wednesday reduced by 4.29% less by ₹ 6,134.25.
Published – 06 August, 2025 10:31 pm IST
